• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于高级别胶质瘤PET成像的非常规示踪剂。

Non-routine Tracers for PET Imaging of High-grade Glioma.

作者信息

Frosina Guido

机构信息

Mutagenesis Unit, IRCCS AOU San Martino - IST, Genoa, Italy

出版信息

Anticancer Res. 2016 Jul;36(7):3253-60.

PMID:27354581
Abstract

Thorough imaging is crucial for diagnosis and treatment of high-grade gliomas (HGG), lethal brain tumours with median survival ranging 1-5 years after diagnosis. Positron-emission tomography (PET) is acquiring importance in imaging of HGG since it has the formidable advantage of providing information on tumour metabolism that may be critical for correct diagnosis and treatment planning. Recently employed PET tracers designed for the non-routine investigation of specific aspects of HGG metabolism, including hypoxia, neoangiogenesis, expression of integrins and stem cell markers, are reviewed herein. A thorough choice from among these non-routine tracers may provide important metabolic information complementing those obtained with more common PET analyses, for the sake of diagnostic, prognostic, treatment planning or research purposes.

摘要

全面的影像学检查对于高级别胶质瘤(HGG)的诊断和治疗至关重要,HGG是一种致命的脑肿瘤,诊断后的中位生存期为1至5年。正电子发射断层扫描(PET)在HGG的影像学检查中越来越重要,因为它具有提供肿瘤代谢信息的巨大优势,这对于正确的诊断和治疗规划可能至关重要。本文综述了最近用于HGG代谢特定方面非常规研究的PET示踪剂,包括缺氧、新生血管形成、整合素和干细胞标志物的表达。从这些非常规示踪剂中进行全面选择,可为诊断、预后、治疗规划或研究目的提供补充更常见PET分析所获得信息的重要代谢信息。

相似文献

1
Non-routine Tracers for PET Imaging of High-grade Glioma.用于高级别胶质瘤PET成像的非常规示踪剂。
Anticancer Res. 2016 Jul;36(7):3253-60.
2
Positron emission tomography of high-grade gliomas.高级别胶质瘤的正电子发射断层扫描
J Neurooncol. 2016 May;127(3):415-25. doi: 10.1007/s11060-016-2077-1. Epub 2016 Feb 20.
3
[Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].[氨基酸正电子发射断层扫描在脑胶质瘤诊断及治疗管理中的应用]
Fortschr Neurol Psychiatr. 2012 Jan;80(1):17-23. doi: 10.1055/s-0031-1281851. Epub 2011 Dec 12.
4
The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET.肿瘤与脑比值之和提高了使用18F-FET PET诊断神经胶质瘤的准确性。
PLoS One. 2015 Oct 15;10(10):e0140917. doi: 10.1371/journal.pone.0140917. eCollection 2015.
5
A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma.一种新型的、集成的PET引导的磁共振波谱技术,可更准确地对高级别胶质瘤进行初步诊断。
Neuroradiol J. 2016 Jun;29(3):193-7. doi: 10.1177/1971400916639962. Epub 2016 Apr 27.
6
Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.3'-去氧-3'-[18F]氟代胸苷 PET 与 O-(2-[18F]氟乙基)-L-酪氨酸 PET 在新诊断脑胶质瘤患者中的比较。
Nucl Med Biol. 2012 Oct;39(7):977-81. doi: 10.1016/j.nucmedbio.2012.02.009. Epub 2012 Apr 5.
7
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?使用动态氨基酸PET成像对脑肿瘤进行无创分级:11C-蛋氨酸是否可行?
Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2082-7. doi: 10.1007/s00259-007-0557-4. Epub 2007 Sep 1.
8
Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.正电子发射断层扫描成像在神经胶质瘤中的应用:在临床诊断、评估预后和治疗效果以及检测复发中的应用。
Eur J Neurol. 2017 Oct;24(10):1255-e70. doi: 10.1111/ene.13385. Epub 2017 Aug 11.
9
Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomas.(68)Ga-蛙皮素和(18)F-FDG-PET对低级别胶质瘤患者恶性转化与肿瘤复发的鉴别诊断
Hell J Nucl Med. 2008 Sep-Dec;11(3):149-52.
10
Investigational PET tracers for high-grade gliomas.用于高级别胶质瘤的正电子发射断层显像(PET)示踪剂研究
Q J Nucl Med Mol Imaging. 2018 Sep;62(3):281-294. doi: 10.23736/S1824-4785.18.03105-9. Epub 2018 Jun 4.

引用本文的文献

1
Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme.用于多形性胶质母细胞瘤 PET 成像的放射性标记肽的临床前评估。
Molecules. 2019 Jul 8;24(13):2496. doi: 10.3390/molecules24132496.
2
The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).分子功能影像学在临床肿瘤学中的不断发展:走向精准医学和放射组学(上)。
Mol Diagn Ther. 2019 Feb;23(1):1-26. doi: 10.1007/s40291-018-0366-4.
3
[Ga]RGD Versus [F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide.
[Ga]RGD 与 [F]FDG PET 成像在贝伐单抗和/或替莫唑胺治疗人胶质母细胞瘤肿瘤模型中的应用。
Mol Imaging Biol. 2019 Apr;21(2):297-305. doi: 10.1007/s11307-018-1224-9.
4
PET imaging of Ga-NODAGA-RGD, as compared with F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma.在移植性胶质母细胞瘤实验啮齿动物模型中,与氟代脱氧葡萄糖相比,镓标记的NODAGA-RGD的正电子发射断层显像(PET)。
EJNMMI Res. 2018 Jun 15;8(1):51. doi: 10.1186/s13550-018-0405-5.
5
A Survival Score Based on Symptoms and Performance Status for Patients with High-grade Gliomas Receiving Radiochemotherapy.基于症状和体能状态的高级别胶质瘤患者接受放化疗后的生存评分
In Vivo. 2017 Jul-Aug;31(4):689-693. doi: 10.21873/invivo.11114.